Bhinder, M. M., Naeem, A., Khudayar, M., Sohail, A., Kamran, A. (2025). Comparing the bleeding risk in hepatocellular carcinoma patients treated with atezolizumab/bevacizumab versus durvalumab plus tremelimumab.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e13882